Research Highlights/News

2026 | 2024 | 2023 | 2022 | 2021

»  Look for consumer stories click here

2026

Press Releases:

• Defense Health Program Department of War Multiple Sclerosis Research Program Anticipated Funding Opportunities for Fiscal Year 2026 (FY26)

2024

Research Highlights:

• CDMRP Funds Research to Support Service Members and Veterans with Multiple Sclerosis
• Glucagon-Like Peptide-1 Receptor Agonist as New Therapeutics for Multiple Sclerosis

2023

Research Highlights:

• Bioengineered Particles to Promote Regulatory T Cells and Modulate the Immune System in Transplantation and Multiple Sclerosis

2022

Press Releases:

• CDMRP-Funded Research Leads to FDA Breakthrough Device Designation for MS Blood Biomarker Test
  May 13, 2022

Research Highlights:

• Fitness Trackers and Smartphones Used to Predict Behavior Changes in People with Multiple Sclerosis During the COVID-19 Stay-at-Home Mandate
• Physical Telerehabilitation Program for Multiple Sclerosis Patients Improves Patients’ Quality of Life

2021

Research Highlights:

• Reduced Disease Severity Following Novel Angiotensin 1-7 Treatment in MS Mouse Model
• Imaging Measures Reflect Cognitive Changes Over Time in Multiple Sclerosis Patients
• Exercise Training, Metabolic Changes, and Symptoms in People with MS
• Exploring Remyelination in MS: Myelin, Metformin, and Mitochondria

Top of Page